Qingdao Huanghai Pharmaceutical Investment
Status
Global HQ
Qingdao, China
Countries of investment
Investment stages
Industries
About
Qingdao Huanghai Pharmaceutical Co., Ltd., situated in the scenic Laoshan District of Qingdao City, is a leading high-tech enterprise dedicated to the research, development, and commercialization of innovative sustained-release formulations. With a strong commitment to quality, the company leverages cutting-edge technology and extensive expertise to deliver pharmaceutical solutions that meet the evolving needs of healthcare providers and patients. Qingdao Huanghai Pharmaceutical prides itself on adhering to rigorous industry standards and regulatory compliance, ensuring that its products are both effective and reliable. Through continuous investment in R&D and a customer-centric approach, the company aims to enhance patient outcomes and contribute to the advancement of healthcare globally.
Qingdao Huanghai Pharmaceutical Co., Ltd., situated in the scenic Laoshan District of Qingdao City, is a leading high-tech enterprise dedicated to the research, development, and commercialization of innovative sustained-release formulations. With a strong commitment to quality, the company leverages cutting-edge technology and extensive expertise to deliver pharmaceutical solutions that meet the evolving needs of healthcare providers and patients. Qingdao Huanghai Pharmaceutical prides itself on adhering to rigorous industry standards and regulatory compliance, ensuring that its products are both effective and reliable. Through continuous investment in R&D and a customer-centric approach, the company aims to enhance patient outcomes and contribute to the advancement of healthcare globally.
Investment Thesis
Manager's Experience
With a robust background in technology and healthcare sectors, the fund manager has successfully executed over 30 deals across North America and Europe. His strategic style emphasizes a data-driven approach, enabling nuanced assessments of market opportunities. Notable exits include several high-profile IPOs, showcasing a strong track record in fostering growth at the late-stage investment level. His diverse experience reflects a commitment to identifying and nurturing innovative companies poised for significant impact.